Literature DB >> 26487298

Factors Associated with Prescription of Opioids and Co-prescription of Sedating Medications in Individuals with HIV.

Jessica S Merlin1,2, Ashutosh Tamhane3, Joanna L Starrels4, Stefan Kertesz5,6, Michael Saag3, Karen Cropsey7.   

Abstract

Opioids are often prescribed for chronic pain, and opioid risks such as overdose and death are heightened when opioids are co-prescribed with other sedating medications. We investigated factors associated with chronic opioid prescription, alone and in combination with benzodiazepines and muscle relaxants, in a clinical cohort of individuals with HIV. We used multivariable logistic regression models to determine participant clinical and demographic characteristics that are associated with chronic prescription of opioids or chronic co-prescription of opioids with sedating medications. Among 1474 participants, chronic prescription of opioids occurred in 253 individuals (17.2 %), and chronic co-prescription occurred in 90 individuals (6.1 %). Age >50, public insurance as compared to private insurance, and symptoms of depression and anxiety were significantly associated with chronic opioid prescription and chronic co-prescription. Our findings raise concern that opioid prescription and co-prescription of sedating medications occurs disproportionately in patients for whom use is riskier.

Entities:  

Keywords:  Benzodiazepine; Chronic pain; HIV; Muscle relaxant; Opioid

Mesh:

Substances:

Year:  2016        PMID: 26487298      PMCID: PMC4777647          DOI: 10.1007/s10461-015-1178-8

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  50 in total

1.  Prescription long-term opioid use in HIV-infected patients.

Authors:  Michael J Silverberg; Gary Thomas Ray; Kathleen Saunders; Carolyn M Rutter; Cynthia I Campbell; Joseph O Merrill; Mark D Sullivan; Caleb J Banta-Green; Michael Von Korff; Constance Weisner
Journal:  Clin J Pain       Date:  2012-01       Impact factor: 3.442

2.  Report of an HIV clinic-based pain management program and utilization of health status and health service by HIV patients.

Authors:  Ahashta Johnson; Kathleen DiGangi Condon; Ann Celeste Mapas-Dimaya; Judith Schrager; Robert Grossberg; Rosalyn Gonzalez; Sean O'Mahony
Journal:  J Opioid Manag       Date:  2012 Jan-Feb

3.  Pain and physical and psychological symptoms in ambulatory HIV patients in the current treatment era.

Authors:  Jessica S Merlin; Liyi Cen; Amy Praestgaard; Michelle Turner; Aura Obando; Craig Alpert; Sophie Woolston; David Casarett; Jay Kostman; Robert Gross; Ian Frank
Journal:  J Pain Symptom Manage       Date:  2011-11-23       Impact factor: 3.612

4.  An analysis of the root causes for opioid-related overdose deaths in the United States.

Authors:  Lynn R Webster; Susan Cochella; Nabarun Dasgupta; Keri L Fakata; Perry G Fine; Scott M Fishman; Todd Grey; Erin M Johnson; Lewis K Lee; Steven D Passik; John Peppin; Christina A Porucznik; Albert Ray; Sidney H Schnoll; Richard L Stieg; Wayne Wakeland
Journal:  Pain Med       Date:  2011-06       Impact factor: 3.750

5.  A review of opioid prescribing practices and associations with repeat opioid prescriptions in a contemporary outpatient HIV clinic.

Authors:  Nur F Önen; Ernie-Paul Barrette; Enbal Shacham; Toshibumi Taniguchi; Michael Donovan; Edgar T Overton
Journal:  Pain Pract       Date:  2011-11-22       Impact factor: 3.183

6.  Occurrence and characteristics of chronic pain in a community-based cohort of indigent adults living with HIV infection.

Authors:  Christine Miaskowski; Joanne M Penko; David Guzman; Jennifer E Mattson; David R Bangsberg; Margot B Kushel
Journal:  J Pain       Date:  2011-09       Impact factor: 5.820

7.  The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test.

Authors:  K Bush; D R Kivlahan; M B McDonell; S D Fihn; K A Bradley
Journal:  Arch Intern Med       Date:  1998-09-14

8.  Association between opioid prescribing patterns and opioid overdose-related deaths.

Authors:  Amy S B Bohnert; Marcia Valenstein; Matthew J Bair; Dara Ganoczy; John F McCarthy; Mark A Ilgen; Frederic C Blow
Journal:  JAMA       Date:  2011-04-06       Impact factor: 56.272

9.  A history of being prescribed controlled substances and risk of drug overdose death.

Authors:  Leonard J Paulozzi; Edwin M Kilbourne; Nina G Shah; Kurt B Nolte; Hema A Desai; Michael G Landen; William Harvey; Larry D Loring
Journal:  Pain Med       Date:  2011-10-25       Impact factor: 3.750

Review 10.  Polydrug abuse: a review of opioid and benzodiazepine combination use.

Authors:  Jermaine D Jones; Shanthi Mogali; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2012-08-02       Impact factor: 4.492

View more
  16 in total

1.  Brief Report: Longitudinal Opioid Use Among HIV-Infected Patients, 2000 to 2014.

Authors:  Laurence Brunet; Sonia Napravnik; Amy D Heine; Peter A Leone; Joseph J Eron
Journal:  J Acquir Immune Defic Syndr       Date:  2017-05-01       Impact factor: 3.731

2.  Correlates of opioid and benzodiazepine co-prescription among people living with HIV in British Columbia, Canada: A population-level cohort study.

Authors:  Stephanie Parent; Seonaid Nolan; Nadia Fairbairn; Monica Ye; Anthony Wu; Julio Montaner; Rolando Barrios; Lianping Ti
Journal:  Int J Drug Policy       Date:  2019-03-18

3.  CCR5 mediates HIV-1 Tat-induced neuroinflammation and influences morphine tolerance, dependence, and reward.

Authors:  Maciej Gonek; Virginia D McLane; David L Stevens; Kumiko Lippold; Hamid I Akbarali; Pamela E Knapp; William L Dewey; Kurt F Hauser; Jason J Paris
Journal:  Brain Behav Immun       Date:  2017-11-13       Impact factor: 7.217

4.  Study protocol for the targeting effective analgesia in clinics for HIV (TEACH) study - a cluster randomized controlled trial and parallel cohort to increase guideline concordant care for long-term opioid therapy among people living with HIV.

Authors:  Marlene C Lira; Judith I Tsui; Jane M Liebschutz; Jonathan Colasanti; Christin Root; Debbie M Cheng; Alexander Y Walley; Meg Sullivan; Christopher Shanahan; Kristen O'Connor; Catherine Abrams; Leah S Forman; Christine Chaisson; Carly Bridden; Melissa C Podolsky; Kishna Outlaw; Catherine E Harris; Wendy S Armstrong; Carlos Del Rio; Jeffrey H Samet
Journal:  HIV Res Clin Pract       Date:  2019-04

5.  Marijuana Use Is Not Associated With Changes in Opioid Prescriptions or Pain Severity Among People Living With HIV and Chronic Pain.

Authors:  Jessica S Merlin; Dustin Long; William C Becker; Edward R Cachay; Katerina A Christopolous; Kasey R Claborn; Heidi M Crane; Eva Jennifer Edelman; Travis I Lovejoy; William Christopher Mathews; Benjamin J Morasco; Sonia Napravnik; Connall OʼCleirigh; Michael S Saag; Joanna L Starrels; Robert Gross; Jane M Liebschutz
Journal:  J Acquir Immune Defic Syndr       Date:  2019-06-01       Impact factor: 3.731

6.  Functional Impairment and Cognitive Symptoms Among People with HIV Infection on Chronic Opioid Therapy for Pain: The Impact of Gabapentin and Other Sedating Medications.

Authors:  Theresa W Kim; Jeffrey H Samet; Sara Lodi; Simeon D Kimmel; Leah S Forman; Marlene C Lira; Jane M Liebschutz; Emily C Williams; Alexander Y Walley
Journal:  AIDS Behav       Date:  2022-06-23

7.  Concurrent Utilization of Prescription Opioids and Non-opioid Controlled Substances: Rhode Island Prescription Drug Monitoring Program, 2018.

Authors:  Eric P Borrelli; Blake Morphis; Rouba Youssef; Laura C Chambers; Benjamin D Hallowell; Jeffrey Bratberg; Stephen J Kogut
Journal:  R I Med J (2013)       Date:  2020-10-01

8.  Brief Report: The Association of Chronic Pain and Long-Term Opioid Therapy With HIV Treatment Outcomes.

Authors:  Jessica S Merlin; Dustin Long; William C Becker; Edward R Cachay; Katerina A Christopoulos; Kasey Claborn; Heidi M Crane; E Jennifer Edelman; Richard Harding; Stefan G Kertesz; Jane M Liebschutz; W Christopher Mathews; Michael J Mugavero; Sonia Napravnik; Connall C OʼCleirigh; Michael S Saag; Joanna L Starrels; Robert Gross
Journal:  J Acquir Immune Defic Syndr       Date:  2018-09-01       Impact factor: 3.731

9.  Combined HIV-1 Tat and oxycodone activate the hypothalamic-pituitary-adrenal and -gonadal axes and promote psychomotor, affective, and cognitive dysfunction in female mice.

Authors:  Mohammed F Salahuddin; Alaa N Qrareya; Fakhri Mahdi; Dejun Jackson; Matthew Foster; Tamara Vujanovic; J Gaston Box; Jason J Paris
Journal:  Horm Behav       Date:  2019-12-13       Impact factor: 3.587

10.  Prevalence and impact of comorbid chronic pain and cigarette smoking among people living with HIV.

Authors:  Lisa R LaRowe; John D Cleveland; Dustin M Long; Shadi Nahvi; Edward R Cachay; Katerina A Christopoulos; Heidi M Crane; Karen Cropsey; Sonia Napravnik; Conall O'Cleirigh; Jessica S Merlin; Joseph W Ditre
Journal:  AIDS Care       Date:  2021-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.